秋葵
医学
糖尿病
安慰剂
随机对照试验
内科学
血糖
空腹血糖
2型糖尿病
血红蛋白
2型糖尿病
临床试验
胃肠病学
外科
传统医学
内分泌学
生物
病理
替代医学
农学
作者
Ali Saatchi,Naser Aghamohammadzadeh,Samineh Beheshtirouy,Yousef Javadzadeh,Fariba Heshmati Afshar,Saba Ghaffary
摘要
Abstract Okra ( Abelmoschus esculentus ) has traditionally been used in diabetes treatment. This study investigated the effect of Okra whole fruit on blood glucose level of patients with diabetes mellitus type 2 with concomitant use of oral hypoglycemic agents. In this double‐blind randomized clinical trial, 120 diabetic patients were assigned to okra group ( n = 60) and control group ( n = 60). The okra group received 1,000 mg of A.esculentus whole fruit capsules orally, every 6 hr for 8 weeks. The control group received placebo capsule in the same manner. The levels of FBS (fasting blood sugar), BS (blood sugar), and Hemoglobin A1C (HgA1c) were measured at baseline and after intervention in both groups. The levels of FBS, BS, and HgA1c were significantly decreased in okra group within the intervention compared to control group ( p < .05). Moreover, the numbers to treat (NNT) for FBS, BS, and HgA1C were seven, eight, and seven, respectively. Okra whole fruit supplementation has a promising anti‐hyperglycemic effect in patients with diabetes mellitus type 2 who received oral agents. Diabetic patients could benefit from adjuvant therapy of okra with other medication.
科研通智能强力驱动
Strongly Powered by AbleSci AI